SynCath NeuroScience
Cerebral Assist Device for Neurointensive Care
Company Overview
Snapshot
Founded in August 2018 by Ofer Barnea and Omer Doron, SynCath NeuroScience operated with 1–10 employees. The company raised $920,000 across two funding rounds. In January 2019, the company secured a grant from the Israel Innovation Authority.
Business overview
SynCath NeuroScience is a preclinical-stage medical technology startup focused on developing a cerebral assist device for neurointensive care. The company's core technology involves an ECG-synchronized dynamic ICP-modulation probe designed to enhance cerebral blood flow through synchronized deflate-inflate actions within each cardiac cycle. This disposable, autonomous probe is delivered via an external ventricular drain (EVD)-like catheter, initially targeting patients instrumented with an EVD. SynCath NeuroScience operates within the Health Tech & Life Sciences sector, specifically in Medical Devices, Diagnostics Devices, and Medical Treatment & Therapeutics.
Strategic signal
In June 2022, SynCath NeuroScience's technology was highlighted in a news report for its potential to revolutionize neuroscience treatment and save millions. This signals the company's innovative approach in the medical device space and its potential to address critical needs in neurointensive care, attracting attention to its preclinical-stage developments.
Log in to access full profile ›Company Intelligence Q&A
- What is SynCath NeuroScience's primary focus?
- SynCath NeuroScience is a preclinical-stage medical technology startup developing a cerebral assist device for neurointensive care, utilizing ECG-synchronized dynamic ICP-modulation technology.
- When was SynCath NeuroScience founded?
- SynCath NeuroScience was founded in August 2018.
- Who are the founders of SynCath NeuroScience?
- SynCath NeuroScience was founded by Ofer Barnea and Omer Doron.
- What significant funding did SynCath NeuroScience receive in January 2019?
- In January 2019, SynCath NeuroScience secured a grant from the Israel Innovation Authority.
- What is the status of SynCath NeuroScience?
- SynCath NeuroScience is currently non-active, having ceased operations in December 2023.